


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.62%
+37.50%
-1.03%
+5.41%
-2.41%
MNKD
MannKind
$5.36
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$5.3 (+1.13%)
$4.59 (+16.78%)
$3.6 (+48.89%)
$6.8 (-21.18%)
MNKD has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

MNKD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MNKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNKD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is MNKD current stock price?
What are MNKD stock strengths?
What is MNKD Risk Level?
What is MNKD market cap and volume?
What is MNKD current Stock IQ?
Should I buy MNKD stock right now?
Is MNKD a Strong Buy right now?
What does a 'Strong Buy' rating mean for MNKD?
What does a 'Strong Sell' rating mean for MNKD?
What factors influence MNKD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.62%
+37.50%
-1.03%
+5.41%
-2.41%
MNKD
MannKind
Current Price
$5.36
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Chart
$5.3 (+1.13%)
$4.59 (+16.78%)
$3.6 (+48.89%)
$6.8 (-21.18%)
MNKD Analysts Opinion
MNKD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MNKD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNKD Street Sentiment is extremely bullish and have positive views on the near-term outlook
MNKD has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
MNKD Latest Analysis
Truist Securities Initiates Coverage of MannKind (MNKD) with Buy Recommendation. Fintel reports that on November 24 2025 Truist Securities initiated coverage of MannKind (NasdaqGM:MNKD) with a Buy recommendation. Analyst Price Forecast Suggests 83.77% Upside
Today
MannKind to Present at the Jefferies Global Healthcare Conference. DANBURY Conn. and WESTLAKE VILLAGE Calif. Nov. 11 2025 (GLOBE NEWSWIRE) --
Tue Nov 11, 2025
MannKind slides after halting late-stage trial of MNKD-101 for lung disease.
Mon Nov 10, 2025
MannKind outlines FUROSCIX market expansion and Afrezza pediatric launch strategy following record $82M Q3 revenue.
Wed Nov 5, 2025
MannKind Non-GAAP EPS of $0.07 beats by $0.04 revenue of $82.13M beats by $1.88M.
Wed Nov 5, 2025
Mannkind rises after Q3 revenue profit beat.
Wed Nov 5, 2025
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say. Although the revenue and EPS for MannKind (MNKD) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wed Nov 5, 2025
MannKind Corporation Q3 Profit Decreases But Beats Estimates . (RTTNews) - MannKind Corporation (MNK) released a profit for third quarter that Decreased from the same period last year but beat the Street estimates.
Wed Nov 5, 2025
MannKind earnings beat by $0.05 revenue topped estimates.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MNKD Stock trends
MNKD Stock performance
MNKD Stock analysis
MNKD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.